CA2306090A1 - Delivery vehicles for bioactive agents and uses thereof - Google Patents

Delivery vehicles for bioactive agents and uses thereof Download PDF

Info

Publication number
CA2306090A1
CA2306090A1 CA002306090A CA2306090A CA2306090A1 CA 2306090 A1 CA2306090 A1 CA 2306090A1 CA 002306090 A CA002306090 A CA 002306090A CA 2306090 A CA2306090 A CA 2306090A CA 2306090 A1 CA2306090 A1 CA 2306090A1
Authority
CA
Canada
Prior art keywords
composition
oil
nucleic acid
bioactive agent
surface active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002306090A
Other languages
English (en)
French (fr)
Inventor
Christopher W. Mcdaniel
Lawrence L. Kunz
Randell T. Libby
Thomas R. Tice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Southern Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2306090A1 publication Critical patent/CA2306090A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002306090A 1997-10-24 1998-10-23 Delivery vehicles for bioactive agents and uses thereof Abandoned CA2306090A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6311497P 1997-10-24 1997-10-24
US95669497A 1997-10-24 1997-10-24
US60/063,114 1997-10-24
US08/956,694 1997-10-24
PCT/US1998/022552 WO1999021533A2 (en) 1997-10-24 1998-10-23 Delivery vehicles for bioactive agents and uses thereof

Publications (1)

Publication Number Publication Date
CA2306090A1 true CA2306090A1 (en) 1999-05-06

Family

ID=26743057

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306090A Abandoned CA2306090A1 (en) 1997-10-24 1998-10-23 Delivery vehicles for bioactive agents and uses thereof

Country Status (4)

Country Link
EP (1) EP1023045A2 (de)
AU (1) AU1198599A (de)
CA (1) CA2306090A1 (de)
WO (1) WO1999021533A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200957B1 (en) * 1995-12-14 2001-03-13 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
IT1318539B1 (it) * 2000-05-26 2003-08-27 Italfarmaco Spa Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
US20020155084A1 (en) * 2000-06-02 2002-10-24 The Regents Of The University Of The Michigan Nanoemulsion formulations
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
ES2383303T3 (es) * 2005-11-10 2012-06-20 Chemi S.P.A. Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
WO2014117021A2 (en) 2013-01-25 2014-07-31 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
EP3044329B1 (de) 2013-09-13 2020-04-22 Life Technologies Corporation Vorbereitung einer vorrichtung unter verwendung von kondensierten nukleinsäurepartikeln
WO2017223199A1 (en) * 2016-06-22 2017-12-28 Xcell Biosciences, Inc. Methods for increasing cell culture transfection efficiency and cellular reprogramming
WO2025210141A1 (en) * 2024-04-05 2025-10-09 Boehringer Ingelheim Vetmedica Gmbh Delivery system useful for topical administration of rna

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171125A (en) * 1966-06-08 1969-11-19 Glaxo Lab Ltd Improvements in or relating to Injectable Preparations
WO1990014837A1 (en) * 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
CA2153882A1 (en) * 1993-01-21 1994-08-04 Masataka Katsuma Novel transdermal absorption preparation
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
WO1999021533A2 (en) 1999-05-06
AU1198599A (en) 1999-05-17
EP1023045A2 (de) 2000-08-02
WO1999021533A3 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
US20020169138A1 (en) Delivery vehicles for bioactive agents and uses thereof
JP7600208B2 (ja) 拘束された脂質を含むナノ材料およびその使用
US6245349B1 (en) Drug delivery compositions suitable for intravenous injection
DE69736432T2 (de) Hemmung der bcl-2 protein expression durch liposomale antisense-oligodeoxynukleotide
Choi et al. Low toxicity of cationic lipid-based emulsion for gene transfer
JP2002521423A (ja) 遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子
WO2019223728A1 (zh) 甘露糖靶向的纳米制剂及其制备和应用
US8333959B2 (en) Ex-vivo application of solid microparticulate therapeutic agents
TW201124425A (en) Parenteral formulations of gemcitabine derivatives
KR20090130081A (ko) 2상 지질-소포 조성물 및 질내 송달에 의한 자궁경부 이형성증의 치료 방법
US20200368174A1 (en) Particles for targeted delivery of active agents into adipose stromal cells
EP4501360A1 (de) Lipidnanopartikel zur abgabe von nukleinsäure an milzgewebe und verfahren zur abgabe von nukleinsäure an milzgewebe damit
JP5382682B2 (ja) 薬物送達複合体
AU1198599A (en) Delivery vehicles for bioactive agents and uses thereof
JP2022514991A (ja) 安定な麻酔薬製剤および関連する剤形
WO2023230711A1 (en) Lipid nanoparticle for the delivery of rna
WO2023054243A1 (ja) 細胞指向性を有する脂質ナノ粒子
EP4410276A1 (de) Lipidnanopartikel zum transport von nukleinsäuren in lymphendothelzellen
EP4410275A1 (de) Lipidnanopartikel zur abgabe von nukleinsäure an hirngewebe
NZ518799A (en) Delivery vehicles for bioactive agents comprising oil in water
WO1991007973A1 (en) Fat emulsion
AU2005204689A2 (en) Lipid compositions and use thereof
EP4516295A1 (de) Ph-induzierbare strukturwechselnde lipidnanovektoren, halbsynthetische extrazelluläre vesikel, verfahren zur herstellung davon und verwendungen davon
CN101099866A (zh) 泊洛沙姆修饰的胆固醇共聚物及其应用
US20230310647A1 (en) Targeting cartilage egfr pathway for osteoarthritis treatment

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued